Medicare Enrolled

Dr. Subramanya Rao, M.D.

Medical Oncology · Tinley Park, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
17333 LA GRANGE RD STE 200, Tinley Park, IL 60487
7083421900
In practice since 2006 (20 years)
NPI: 1740256783 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rao? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rao

Dr. Subramanya Rao is a medical oncology specialist in Tinley Park, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rao performed 1,144 Medicare services across 637 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rao received a total of $62,255 from 77 pharmaceutical and/or device companies across 726 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 35% volume in IL $62,255 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,144
Medicare services
Top 35% in IL for medical oncology
637
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~57 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
615 $76 $230
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
308 $112 $311
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
90 $93 $225
New patient office visit, complex (60-74 min) 83 $146 $449
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
48 $134 $439
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$62,255
Total received (2018-2024)
Avg $8,894/year across 7 years
Top 11% in IL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
726
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$43,485 (69.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,776 (20.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,993 (9.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,147
2023
$1,434
2022
$4,083
2021
$2,112
2020
$25,375
2019
$12,482
2018
$13,622

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Karyopharm Therapeutics Inc.
$1,100
Novartis Pharmaceuticals Corporation
$244
PFIZER INC.
$217
Merck Sharp & Dohme LLC
$192
Genentech USA, Inc.
$147
Astellas Pharma US Inc
$128
Janssen Biotech, Inc.
$127
Alexion Pharmaceuticals, Inc.
$101
AstraZeneca Pharmaceuticals LP
$99
Gilead Sciences, Inc.
$95
ABBVIE INC.
$73
Blueprint Medicines Corporation
$70
E.R. Squibb & Sons, L.L.C.
$65
Mirati Therapeutics, Inc.
$62
Celgene Corporation
$57
Agios Pharmaceuticals, Inc.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$48
Lilly USA, LLC
$41
PharmaEssentia USA Corporation
$37
GlaxoSmithKline, LLC.
$34
Tempus AI, Inc
$29
SOBI, INC
$29
ARRAY BIOPHARMA INC
$26
SERVIER PHARMACEUTICALS LLC
$21
Pharmacosmos Therapeutics Inc.
$19
TAIHO ONCOLOGY, INC.
$19
BeiGene USA, Inc.
$16
Top 3 companies account for 49.6% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$15,268
PFIZER INC.
$5,405
Janssen Biotech, Inc.
$4,778
AstraZeneca Pharmaceuticals LP
$4,413
Celgene Corporation
$3,582
Epizyme, Inc.,
$2,903
Takeda Pharmaceuticals U.S.A., Inc.
$2,299
Janssen Scientific Affairs, LLC
$2,219
Bayer HealthCare Pharmaceuticals Inc.
$1,950
Exelixis Inc.
$1,657
Eisai Inc.
$1,558
AMAG Pharmaceuticals, Inc.
$1,541
Seattle Genetics, Inc.
$1,427
Karyopharm Therapeutics Inc.
$1,175
Heron Therapeutics, Inc.
$1,100
Merck Sharp & Dohme Corporation
$942
Novartis Pharmaceuticals Corporation
$867
Adaptive Biotechnologies Corporation
$823
E.R. Squibb & Sons, L.L.C.
$806
ASD SPECIALTY HEALTHCARE, LLC
$697
Lilly USA, LLC
$665
Genentech USA, Inc.
$585
EMD Serono, Inc.
$432
Merck Sharp & Dohme LLC
$412
Astellas Pharma US Inc
$392
Seagen Inc.
$339
Pharmacyclics LLC, An AbbVie Company
$284
Janssen Pharmaceuticals, Inc
$206
Gilead Sciences, Inc.
$204
Dova Pharmaceuticals
$194
TESARO, Inc.
$157
JAZZ PHARMACEUTICALS INC.
$153
ABBVIE INC.
$148
BeiGene USA, Inc.
$146
Incyte Corporation
$144
Amgen Inc.
$142
GlaxoSmithKline, LLC.
$134
ASD Specialty Healthcare, LLC
$121
Alexion Pharmaceuticals, Inc.
$121
Puma Biotechnology, Inc.
$116
Rigel Pharmaceuticals, Inc.
$109
Global Blood Therapeutics, Inc.
$108
GENZYME CORPORATION
$99
Regeneron Healthcare Solutions, Inc.
$94
Blueprint Medicines Corporation
$94
AbbVie, Inc.
$93
ADC Therapeutics America, Inc.
$84
Mirati Therapeutics, Inc.
$80
Agios Pharmaceuticals, Inc.
$75
MorphoSys, US Inc.
$74
Coherus Biosciences Inc.
$64
Kite Pharma, Inc.
$57
TAIHO ONCOLOGY, INC.
$55
G1 Therapeutics, Inc.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Myriad Genetic Laboratories, Inc.
$44
Pharmacosmos Therapeutics Inc.
$43
PharmaEssentia USA Corporation
$37
Cardinal Health 108, LLC
$34
Melinta Therapeutics, Inc.
$32
Tempus AI, Inc
$29
Foundation Medicine, Inc.
$29
SOBI, INC
$29
AbbVie Inc.
$28
Kyowa Kirin, Inc.
$28
ARRAY BIOPHARMA INC
$26
Sun Pharmaceutical Industries Inc.
$25
Pharmacyclics LLC, an AbbVie Company
$25
Nestle HealthCare Nutrition Inc.
$24
Myovant Sciences Inc.
$23
SERVIER PHARMACEUTICALS LLC
$21
Array BioPharma Inc.
$19
Clovis Oncology, Inc.
$17
Taiho Oncology, Inc.
$16
Secura Bio, Inc.
$16
Spectrum Pharmaceuticals Inc.
$14
Helsinn Therapeutics (U.S.), Inc.
$12
Top 3 companies account for 40.9% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALOXI · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BALVERSA · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Baxdela · Braftovi · CALQUENCE · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · DARZALEX · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Erleada · FARESTON · FERAHEME · FOUNDATIONONE · Farydak · Fedratinib · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · Prolia · REBLOZYL · ROLVEDON · RYBREVANT · Revlimid · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SUTENT · Stivarga · TASIGNA · TAZVERIK · TECENTRIQ · TEPMETKO · TUKYSA · Tavalisse · Trodelvy · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Voranigo · WELIREG · XALKORI · XARELTO · XPOVIO · XTANDI · Xofigo · Xtandi · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a medical oncology specialist in Tinley Park?
Compare medical oncologists in the Tinley Park area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
38
Per 100K population
0.7
County median income
$81,797
Nearest hospital
PALOS COMMUNITY HOSPITAL
7.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rao is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 11% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rao experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rao performed 615 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rao receive payments from pharmaceutical companies?
Yes. Dr. Rao received a total of $62,255 from 77 companies across 726 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rao's costs compare to other medical oncologists in Tinley Park?
Dr. Rao's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →